Clinical Research Directory
Browse clinical research sites, groups, and studies.
Back to Studies
ACTIVE NOT RECRUITING
NCT06138613
PHASE3
Motion Delos: An Open Label Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness
Sponsor: Vanda Pharmaceuticals
View on ClinicalTrials.gov
Summary
An open label study to investigate the safety and efficacy of tradipitant in participants affected by motion sickness during travel
Official title: Motion Delos: An Open Label Study to Investigate the Safety and Efficacy of Tradipitant in Participants Affected by Motion Sickness During Travel
Key Details
Gender
All
Age Range
18 Years - 75 Years
Study Type
INTERVENTIONAL
Enrollment
705
Start Date
2023-02-27
Completion Date
2026-06-30
Last Updated
2025-11-21
Healthy Volunteers
No
Conditions
Interventions
DRUG
Tradipitant
Oral Capsule
Locations (1)
Santa Monica Clinical Trials
Santa Monica, California, United States